134
Participants
Start Date
March 3, 2017
Primary Completion Date
December 31, 2023
Study Completion Date
January 30, 2025
Apomorphine
Apomorphine (5 mg/ml) is supplied as solution for infusion in a 10 ml glass ampoule Hourly flow rate is adjusted during the whole duration of the study to doses of minimum 3 mg/hour up to a maximum of 10 mg/hour
Best Medical Treatment
Most efficient single treatment of Parkinson's disease symptoms or their combinations, in concordance with the guidelines of the European Federation of Neurological Societies
APHM, hospital of Timone, Marseille
Caen University Hospital, Caen
Caremeau University Hospital, Nîmes
Purpan University Hospital, Toulouse
Pellegrin University Hospital, Bordeaux
Clinique Beau-Soleil, Montpellier
Montpellier University Hospital, Montpellier
Rennes University Hospital, Rennes
Saint-Etienne University Hospital, Saint-Etienne
Laennec Hospital, Nantes
Nancy University Hospital, Nancy
Lille University Hospital, Lille
Clermont-Ferrand University Hospital, Clermont-Ferrand
Bayonne Côte Basque Hospital, Bayonne
Hautepierre University Hospital, Strasbourg
Pierre Wertheimer Hospital, Bron
Pitié-Salpêtriere Hospital, Paris
Amiens University Hospital, Amiens
Poitiers University Hospital, Poitiers
Pasteur 2 University Hospital, Nice
Rennes University Hospital
OTHER